World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
138
Citations
104140
World Ranking
1795
National Ranking
1027

Overview

Curt D. Furberg is affiliated with Wake Forest University in the United States. Their research spans multiple disciplines, primarily within Medicine and Economics, Econometrics, and Finance. The scientist has contributed notably to the understanding of cardiovascular health, pharmaceutical economics, and kidney function, among other topics.

The main fields of study covered in their work include:

  • Medicine
  • Economics, Econometrics and Finance

Within these broader fields, their subfields of study encompass:

  • Economics and Econometrics
  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nephrology
  • Emergency Medicine

Their research topics frequently address:

  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • HIV-related health complications and treatments
  • Dialysis and Renal Disease Management
  • Chronic Kidney Disease and Diabetes

Curt D. Furberg has a record of publications in a variety of scientific venues. The most frequent publication venues are:

  • The Lancet
  • UNC Libraries
  • The Lancet Diabetes & Endocrinology
  • JAMA Internal Medicine
  • Cochrane Database of Systematic Reviews

Recent significant papers include:

  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022, The Lancet)
  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis (2024, The Lancet Diabetes & Endocrinology)
  • Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults (2022, JAMA Internal Medicine)
  • Questioning statin therapy for older patients (2020, The Lancet)
  • Pharmaceutical policies: effects on rational drug use (2020, Cochrane Database of Systematic Reviews)

The scientist collaborates frequently with a group of coauthors, including:

  • Christina Reith
  • Colin Baigent
  • Lisa Blackwell
  • Jonathan Emberson
  • Enti Spata

Best Publications

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

    Stephen Hulley;Deborah Grady;Trudy Bush;Curt Furberg

  • The cardiovascular health study: Design and rationale

    Linda P. Fried;Nemat O. Borhani;Paul Enright;Curt D. Furberg

  • Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)

    Stephen Hulley;Curt Furberg;Elizabeth Barrett-Connor;Jane Cauley

  • Incidence of and Risk Factors for Atrial Fibrillation in Older Adults

    Bruce M. Psaty;Teri A. Manolio;Lewis H. Kuller;Richard A. Kronmal

  • Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care

    Curt D. Furberg;Jackson T. Wright;Barry R. Davis;Jeffrey A. Cutler

  • A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

    Kevin E. Thorpe;Merrick Zwarenstein;Andrew D. Oxman;Shaun Treweek

  • Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

    D M Herrington;D M Reboussin;K B Brosnihan;P C Sharp

  • Nifedipine Dose-Related Increase in Mortality in Patients With Coronary Heart Disease

    Curt D. Furberg;Bruce M. Psaty;Jeffrey V. Meyer

  • Primary Prevention of Ischemic Stroke A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association

    L. B. Goldstein;R. Adams;K. Becker;C. D. Furberg

  • Primary Prevention of Ischemic Stroke A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association

    Larry B. Goldstein;Robert Adams;Kyra Becker;Curt D. Furberg

  • Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)

    Curt D. Furberg;Bruce M. Psaty;Teri A. Manolio;Julius M. Gardin

  • Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation

    John D. Brunzell;Michael Davidson;Curt D. Furberg;Ronald B. Goldberg

  • Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

    Bruce M. Psaty;Thomas Lumley;Curt D. Furberg;Gina Schellenbaum

  • Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

    John D. Brunzell;Michael Davidson;Curt D. Furberg;Ronald B. Goldberg

  • The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

    Bruce M. Psaty;Susan R. Heckbert;Thomas D. Koepsell;David S. Siscovick

  • Health Outcomes Associated with Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis

    Bruce M. Psaty;Nicholas L. Smith;David S. Siscovick;Thomas D. Koepsell

  • Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events

    Bertram Pitt;Robert P. Byington;Curt D. Furberg;Donald B. Hunninghake

  • Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

    Sonal Singh;Yoon K. Loke;Curt D. Furberg

  • Genome-wide meta-analyses identify multiple loci associated with smoking behavior

    Helena Furberg;Yunjung Kim;Jennifer Dackor;Eric Boerwinkle

Frequent Co-Authors

Bruce M. Psaty
Bruce M. Psaty University of Washington
Teri A. Manolio
Teri A. Manolio National Institutes of Health
David L. DeMets
David L. DeMets University of Wisconsin–Madison
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh
Barry R. Davis
Barry R. Davis The University of Texas Health Science Center at Houston
Michael H. Alderman
Michael H. Alderman Albert Einstein College of Medicine
Jeffrey A. Cutler
Jeffrey A. Cutler National Institutes of Health
Jeff D. Williamson
Jeff D. Williamson Wake Forest University
Susan R. Heckbert
Susan R. Heckbert University of Washington
David S. Siscovick
David S. Siscovick University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine but want flexibility, several accredited nursing programs are now available online. These options suit both aspiring nurses and current professionals looking to advance. Understanding how much is online nursing school can help you budget for your education and choose a program that fits your goals.

For those aiming to become nurse practitioners, researching the cheapest online fnp programs can make graduate-level study more affordable. Current RNs seeking advancement may be interested in the average cost of rn to bsn programs, which can vary by school and provide a quicker route to career growth.

Additionally, nurses interested in teaching or leadership might pursue a terminal degree through doctorate in nursing education online programs, offering flexibility for working professionals. Exploring these pathways can broaden your career options within healthcare, often at a more accessible cost and with scheduling flexibility compared to traditional on-campus programs.

Best Scientists Citing Curt D. Furberg

Trending Scientists

Recently Published Articles